Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
The Conversation logo

Do you own an oximeter? If so, do you know how and when to use it? It could save your life.

COVID-19 has killed at least 60,000 people in the UK. Many who die have a sudden drop in their blood oxygen levels a day or two before their lungs fail. Unlike in many other chest diseases (asthma, for example), COVID-19 can cause a severe drop in blood oxygen level without any associated breathlessness.

Because of this, people with this “silent hypoxia” are unlikely to seek the urgent help they need, unless they regularly measure their blood oxygen level or their condition deteriorates. If they realise something is wrong, they may reach hospital just in time to receive oxygen therapy (and, if necessary, ventilation). Others are admitted too late to save – or die at home.

The blood oxygen level is one of the strongest predictors of death in COVID-19, and early oxygen improves survival. So it’s time to learn to measure yours and to know what to do if it’s low.

Read the full article on The Conversation website, co-written by Professor Trish Greenhalgh (Nuffield Department of Primary Care Health Sciences)

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

New research sheds light on how ultrasound could be used to treat psychiatric disorders

A new study in macaque monkeys has shed light on which parts of the brain support credit assignment processes (how the brain links outcomes with its decisions) and, for the first time, how low-intensity transcranial ultrasound stimulation (TUS) can modulate both brain activity and behaviours related to these decision-making and learning processes.

Rosalind Franklin Institute and Pharmacology announce strategic partnership in Next Generation Chemistry

The Rosalind Franklin Institute and the University of Oxford’s Department of Pharmacology have entered into a strategic partnership for Next Generation Chemistry.

Christoph Treiber awarded ERC Starting Grant to investigate the origins of behavioural diversity

Congratulations are in order for postdoctoral research scientist Dr Christoph Treiber who has been awarded a Starting Grant from the European Research Council. His funded project will investigate the genetic components that may contribute to diversity of brain function and behaviour.

New blood-based test is the first ever to simultaneously identify if a patient has cancer and if it has spread

A publication by University of Oxford researchers describes a new minimally invasive and inexpensive blood test that can identify cancer in patients with non-specific symptoms. The early success of this technology makes it the first blood-based test that not only detects cancer in this population but can simultaneously identify if a cancer has spread.

New Year's Honours 2022

Members of the Medical Sciences Division have been recognised in the New Year's Honours list for 2022.

Oxford team publish blueprint for making millions of doses of a new vaccine within 100 days

The University of Oxford’s vaccine manufacturing research team has today published a pre-print paper demonstrating the feasibility of a step change in the speed and volume of production of adenovirus-vectored vaccines against new virus variants or other future pandemics.